Navigation Links
For Some on Dialysis, Anemia Drugs Pose Risks
Date:3/2/2010

ported in the March 3 issue of the Journal of the American Medical Association.

For the study, Winkelmayer's team looked at how ESAs were used in about 4,500 dialysis centers across the United States, analyzing data from people treated with ESAs and intravenous iron. They then looked at one-year death rates among the centers' patients.

The researchers found that people with the most severe anemia, with a hematocrit of less than 30 percent, benefited most from aggressive treatment with ESAs, while those with less severe anemia did not. The lower the hematocrit, the more anemic the person.

Less anemic people, those with hematocrits greater than 36 percent, had an 11 percent higher risk for dying if they received aggressive ESA treatment than did similar people whose anemia was treated less aggressively. Among those with hematocrits of 30 percent and 36 percent, aggressive or non-aggressive treatment with ESAs had no effect on mortality, the researchers found.

The findings for treatment with intravenous iron were the same as those for ESAs, Winkelmayer said. Centers that used more aggressive treatment with intravenous iron at low hematocrit had better outcomes, and more aggressive iron use among people with relatively higher hematocrit was associated with more deaths, he noted.

Anemia is a common complication of kidney disease. There are three ESAs sold in the United States to treat anemia: darbepoetin alfa, marketed by Amgen as Aranesp, and epoetin alfa, marketed by Amgen as Epogen and by Johnson & Johnson as Procrit.

ESAs were introduced in 1989, but safety questions have come to light that have brought their use into question. For example, the drugs were promoted as a way to counter the debilitating effects of chemotherapy, but studies have found that the drugs can cause tumors to grow faster, shortening people's lives.

In cancer patients, the drugs are now mostly used as palliative ca
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. For People on Dialysis, Too Thin Can Be Risky
2. FDA Tightens Controls on Anemia Drugs
3. Anemia drug not helpful for kidney disease patients
4. Anemia Drugs May Cause Deadly Blood Clots
5. Drugs to treat anemia in cancer patients linked to thromboembolism
6. Will New Anemia Drug Top Current Treatments?
7. Anemia Drug May Raise Stroke Risk in Kidney Patients
8. Large Study of Anemia Treatment in Chronic Kidney Disease Patients Not on Dialysis Published in the New England Journal of Medicine Failed to Meet Primary Efficacy Endpoints
9. Replication at DNA damage sites highlights Fanconi anemia and breast cancer proteins
10. How to confirm the causes of iron deficiency anemia in young women
11. Anemia associated with greater risk of death in heart disease patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog post explaining ... , Clients can review important auto insurance quotes ... provides important advantages for clients who need affordable financial ... not have coverage for their vehicles can purchase a ... hour. Many agencies offer important discounts and drivers can ...
(Date:4/18/2015)... Patients who undergo radiation for a ... in life, but the disease is likely to differ ... to radiation. Surviving Mesothelioma has just posted the details ... here to read it now. , Scientists from ... 45 patients who had both a hematologic cancer (like ...
(Date:4/18/2015)... More than 2000 styles of newly designed prom dresses ... store carrying celebrity inspired special occasion dresses. With the ... dresses for their prom. For those who are still ... would be an ideal choice. , "We have ... by the most loved styles seen at this years ...
(Date:4/18/2015)... April 18, 2015 “ ArcAngel ” was ... takes a look at the latest and coolest ... Troohey, the host of AppWatch and technology expert, conducted the ... personal safety app. , In a turbulent world, people ... Calling 911 should always be their first move, but some ...
(Date:4/17/2015)... 18, 2015 Heritage Woods of McLeansboro, ... Supportive Living Week Celebration on April 20 with a ... healthy mind, body and soul. , The community, which ... serves older adults of all incomes, including those on ... , Supportive Living Week is observed every April and ...
Breaking Medicine News(10 mins):Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:New Study Examines Relationship Between Radiation for Hematologic Cancers and Development of Mesothelioma, According to Surviving Mesothelioma 2Health News:Prom Dresses 2015 on Sale at TheCelebrityDresses.com 2Health News:A Personal Safety Application was Featured on NewsWatch Television 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 2Health News:Heritage Woods of McLeansboro Affordable Assisted Living to Celebrate Supportive Living Week 3
... syndrome (BCS) results from hepatic venous outflow obstruction,at ... atrium. Few patients respond to,medical treatment (anticoagulation ... to restore the hepatic blood flow. Restoring outflow ... balloon dilatation stenting is the management of ...
... TUESDAY, March 15 (HealthDay News) -- Guidelines for children,s ... updated, say researchers who reviewed 69 studies that included ... produced new reference ranges that differ widely from existing ... University in the United Kingdom, and colleagues. The reference ...
... March 14 If all eligible patients filled their prescriptions ... amount to nearly $6 billion, according to a University of ... the March 14 issue of Archives of Internal Medicine ... national savings from a broad use of discounted generic medication ...
... Heavy alcohol consumption, specifically three or more glasses ... risk of death from pancreatic cancer, according to a ... of Internal Medicine, one of the JAMA/Archives journals. ... is causally related to several cancers, including oral ...
... HealthDay Reporter , MONDAY, March 14 (HealthDay ... breast cancer, tamoxifen can protect against the disease for ... medical costs, new research suggests. For years, women ... tamoxifen as a preventive measure. But previous cost-effectiveness research ...
... , MONDAY, March 14 (HealthDay News) -- Women may ... a diet rich in two types of B vitamins, a ... and riboflavin (B2) in their food significantly reduced their risk ... fortified cereals, whole grains, beans and nuts, and researchers said ...
Cached Medicine News:Health News:Updates Urged for Kids' Heart, Breathing Rate Guidelines 2Health News:Use of $4 generic drug programs could save society billions of dollars, study shows 2Health News:Heavy drinking associated with increased risk of death from pancreatic cancer 2Health News:Breast Cancer Drug Tamoxifen Saves Lives, Medical Costs: Study 2Health News:Breast Cancer Drug Tamoxifen Saves Lives, Medical Costs: Study 3Health News:Diets Rich in Vitamin B May Help Prevent PMS, Study Finds 2
(Date:4/17/2015)... , April 17, 2015 Contego Medical, ... Embolic Protection™ filter platform for angioplasty balloon and ... $5.6 million Series B financing round led by ... with a focus on medical devices, biopharmaceuticals, diagnostics ... also included Mountain Group Partners, Lookout Capital and ...
(Date:4/17/2015)... MINNEAPOLIS , April 17, 2015 Nonin ... announced that President and Chief Operating Officer Steve ... Philip Isaacson is expanding his role as Chief ... his role as Chief Technology Officer. Operations will transition ... " Steve Bucholz has been instrumental to ...
(Date:4/17/2015)... and Markets ( http://www.researchandmarkets.com/research/dl9gbg/admetoxicology ) has announced ... Strategic Business Report" report to their offering. ... Testing in US$ Million by the following Segments: Toxicology ... The report provides separate comprehensive analytics for the US, ... , Europe , Asia-Pacific ...
Breaking Medicine Technology:Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 3Nonin Medical's Philip Isaacson Expands CEO Role; President and COO Steve Bucholz to Retire May 1 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2
... Reportlinker.com announces that a new market ... Depression Therapeutics - Pipeline ... http://www.reportlinker.com/p0656880/Depression-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... Forecasts to 2018 Summary ...
... LAKE, N.J., Oct. 14, 2011 Par Pharmaceutical, Inc., ... PRX ) today announced that it filed ... injunction in U.S. District Court in Washington, D.C. seeking ... information to physicians and other healthcare providers about the ...
Cached Medicine Technology:Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 2Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 3Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 4Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 5Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 6Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 7Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 8Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 9Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018 10Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 2Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 3Par Pharmaceutical Files Declaratory Judgment to Protect First Amendment Rights to Disseminate Truthful Information Regarding Megace® ES 4
... a number of assay steps for ... simple to use benchtop device. The ... stand-alone device but also provides easy ... and standard add-on modules provide maximum ...
... The AVOXimeter 4000 provides a fast, ... bedside. The AVOXimeters patented,state-of-the-art optics yield ... as well as total hemoglobin. When,used ... analyzer, the AVOXimeter,4000 gives a comprehensive ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
The IL 682 is the Gold Standard for CO-Oximetry analysis....
Medicine Products: